Switching From Natalizumab to Fingolimod in Multiple Sclerosis | Zendy

Mikaël Cohen | Zendy; Élisabeth Maillart | Zendy; Ayman Tourbah | Zendy; de Sèze | Zendy; Sandra Vukusic | Zendy; David Brassat | Zendy; Olivier Anne | Zendy; Sandrine Wiertlewski | Zendy; William Camu | Zendy; Sylvie Courtois | Zendy; Aurélie Ruet | Zendy; Marc Debouverie | Zendy; Emmanuelle Le Page | Zendy; Olivier Casez | Zendy; Olivier Heinzlef | Zendy; Bruno Stankoff | Zendy; Bertrand Bourre | Zendy; Giovanni Castelnovo | Zendy; Audrey Rico | Zendy; Éric Berger | Zendy; JeanPhilippe Camdessanché | Zendy; Gilles Defer | Zendy; Pierre Clavelou | Zendy; Abdullatif Al Khedr | Zendy; Hélène Zéphir | Zendy; Agnès Fromont | Zendy; Caroline Papeix | Zendy; Bruno Brochet | Zendy; Jean Pelletier | Zendy; Christine LebrunFrénay | Zendy

AI Assistant Blog Pricing

Open Access

Switching From Natalizumab to Fingolimod in Multiple Sclerosis

Author(s) -

Mikaël Cohen,

Élisabeth Maillart,

Ayman Tourbah,

de Sèze,

Sandra Vukusic,

David Brassat,

Olivier Anne,

Sandrine Wiertlewski,

William Camu,

Sylvie Courtois,

Aurélie Ruet,

Marc Debouverie,

Emmanuelle Le Page,

Olivier Casez,

Olivier Heinzlef,

Bruno Stankoff,

Bertrand Bourre,

Giovanni Castelnovo,

Audrey Rico,

Éric Berger,

JeanPhilippe Camdessanché,

Gilles Defer,

Pierre Clavelou,

Abdullatif Al Khedr,

Hélène Zéphir,

Agnès Fromont,

Caroline Papeix,

Bruno Brochet,

Jean Pelletier,

Christine LebrunFrénay

Publication year - 2014

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2013.6240

Subject(s) - natalizumab , fingolimod , medicine , expanded disability status scale , multiple sclerosis , cohort , adverse effect , immunology

The safety and efficacy of switching from natalizumab to fingolimod have not yet been evaluated in a large cohort of patients with multiple sclerosis (MS) to our knowledge.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog